Paving the Way for a New Class of Antibiotics

2 months ago
At a glance: Revealing the inner workings of drug-resistant bacteria is informing development of much-needed new antibiotics. Experimental drug now in clinical trials takes a new approach to defeating deadly A. baumannii infections. Collaboration between basic research scientists and the pharmaceutical industry drove the advances. Harvard University chemist Daniel Kahne has spent much of his career studying the fundamentals of how bacteria thrive and evade attack. His lab has a special interest in gram-negative bacteria, which have an outer membrane that many antibiotics cannot cross. Get more...
By ANNE J. MANNING | Harvard Gazette

Know Your HBS Staff: Aleksandra Kojić

2 months 1 week ago
For Aleksandra (Ale) Kojić, the marketing manager in Admissions, Harvard Business School (HBS) is more than a workplace—it’s also a home and source of inspiration and opportunity. We talked with Ale about her work, her experience as a professional photographer, and how growing up in war-torn Serbia has influenced her perspective.
Shona Simkin